论文部分内容阅读
目的 :评价高龄急性心肌梗塞患者溶栓治疗的疗效和安全性。方法 :95例发病≤12h的急性心肌梗塞患者中 ,年龄≥70岁34例为高龄组 ,<70岁为低龄组 ,均符合溶栓条件 ,入院后给UK或rSK静脉溶栓 ,120min内观察再通指标 ;记录住院期间心脏事件发生率、病死率、出血并发症。结果 :高龄组与低龄组溶栓治疗后冠状动脉再通率、出血并发症、住院期间病死率无显著性差异(P>0.05) ,心脏事件中高龄组发生率高于低龄组。结论 :高龄急性心肌梗塞患者若无其他明确禁忌症 ,积极溶栓治疗仍是有效安全的可行方法
Objective: To evaluate the efficacy and safety of thrombolytic therapy in elderly patients with acute myocardial infarction. Methods: A total of 95 patients with acute myocardial infarction ≤12h were enrolled in this study. Among them, 34 patients aged 70 years and younger were under 70 years old, all underwent thrombolytic therapy. Thrombolysis was given to UK or rSK after admission, and was observed within 120 minutes Recanalization indicators; record the incidence of cardiac events during hospitalization, mortality, bleeding complications. Results: There was no significant difference in the rate of coronary recanalization, bleeding complications and hospital stay after thrombolytic therapy between the elder group and the younger group (P> 0.05). The incidence of the elderly group was higher than that of the younger group in the cardiac event. Conclusion: In the elderly patients with acute myocardial infarction without other clear contraindications, active thrombolytic therapy is still an effective and safe method